UnitedHealthcareCommercial · Prior Auth · Medical Benefit Drug Policy · Genetics, Pediatrics, EndocrinologyMedium impact
Genglycos™ (Pariglasgene Brecaparvovec-Opnr)
Effective date
Dec 1, 2026
Identified
Nov 7, 2026
Summary
UMR's November 2026 bulletin adds Genglycos (pariglasgene brecaparvovec-opnr), a gene therapy for glycogen storage disease type Ia, to its Review at Launch program, so some members may not be eligible for coverage. Coverage is limited to patients age 8 or older with confirmed GSDIa (bi-allelic G6PC variants or absent G6Pase activity on liver biopsy), current cornstarch therapy, no detectable AAV8 antibodies, no prior gene therapy, prescribing or consultation by a metabolic specialist, no planned inpatient admission solely for the infusion, dosing per FDA labeling, and authorization for one lifetime treatment lasting no more than 45 days from approval.
Get alerts when payers change rules like this one
We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.
01By 2026-12-01: Billing team should review the Genglycos medical benefit criteria with providers who treat GSDIa, and confirm with the UMR Review at Launch policy whether a given member is eligible before scheduling the infusion.
02Before submitting any Genglycos claim for UMR members, billing team should collect and attach documentation of GSDIa confirmation (genetic variant report or liver biopsy enzyme result), cornstarch therapy records, AAV8 antibody results, prior gene therapy history, and metabolic specialist involvement, and should track the 45-day authorization window and one-lifetime limit in the prior authorization tracker.
03Providers and front desk staff should be told that planned inpatient admissions solely for administering Genglycos do not meet criteria, so claims tied to such admissions will be denied without a qualifying indication.
Original notice
Genglycos™ (Pariglasgene Brecaparvovec-Opnr)
uhcprovider.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.